We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.09%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$50.8B
AUM Growth
-$294M
Cap. Flow
-$328M
Cap. Flow %
-0.65%
Top 10 Hldgs %
22.21%
Holding
1,137
New
127
Increased
273
Reduced
442
Closed
122

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$255M
2
TXT icon
Textron
TXT
+$206M
3
AZN icon
AstraZeneca
AZN
+$164M
4
XOM icon
ExxonMobil
XOM
+$124M
5
MRNA icon
Moderna
MRNA
+$121M

Sector Composition

Rank Sector Weight
1 Technology 22.3%
2 Healthcare 15.98%
3 Financials 14.49%
4 Consumer Discretionary 11.52%
5 Communication Services 8.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MSCI icon
201
MSCI
MSCI
$41.8B
$53.4M 0.11%
87,700
-2,700
-3% -$1.65M
PEN icon
202
Penumbra
PEN
$12.7B
$53.3M 0.11%
200,000
+30,000
+18% +$8.06M
ILMN icon
203
Illumina
ILMN
$29.9B
$53.3M 0.1%
134,984
+23,336
+21% +$10.7M
AVTR icon
204
Avantor
AVTR
$9.25B
$53.2M 0.1%
1,300,000
+100,000
+8% +$3.91M
ALGN icon
205
Align Technology
ALGN
$12.4B
$52.5M 0.1%
78,900
-38,300
-33% -$26M
PNTM
206
DELISTED
Pontem Corporation
PNTM
$52.4M 0.1%
5,400,000
B
207
Barrick Mining
B
$62.6B
$52.3M 0.1%
2,900,000
-200,000
-6% -$4.02M
AEVA
208
Aeva Technologies
AEVA
$1.26B
$51.9M 0.1%
1,306,566
-220,000
-14% -$10.2M
CLDX icon
209
Celldex Therapeutics
CLDX
$2.96B
$51.3M 0.1%
950,000
-868,478
-48% -$40.8M
TWTR
210
DELISTED
Twitter, Inc.
TWTR
$51.1M 0.1%
845,500
-217,300
-20% -$14.3M
KLAC icon
211
KLA
KLAC
$239B
$50.5M 0.1%
1,510,700
-72,000
-5% -$2.4M
GPN icon
212
Global Payments
GPN
$23.6B
$50.5M 0.1%
320,560
+248,716
+346% +$43.2M
IQV icon
213
IQVIA
IQV
$38.4B
$49.2M 0.1%
205,200
-3,000
-1% -$757K
CF icon
214
CF Industries
CF
$18.2B
$49.1M 0.1%
879,522
+446,700
+103% +$21.4M
AIG icon
215
American International
AIG
$41.8B
$49.1M 0.1%
893,938
-38,200
-4% -$1.97M
WAT icon
216
Waters Corp
WAT
$36.8B
$48.8M 0.1%
136,665
+39,100
+40% +$15.3M
SWTX
217
DELISTED
SpringWorks Therapeutics
SWTX
$48.6M 0.1%
765,918
+202,450
+36% +$15.6M
PSA icon
218
Public Storage
PSA
$60.9B
$48.6M 0.1%
163,492
+200
+0.1% +$62.8K
EBAY icon
219
eBay
EBAY
$47.6B
$48.4M 0.1%
+694,900
New +$49.8M
CX icon
220
Cemex
CX
$17.1B
$48.4M 0.1%
6,750,000
+3,750,000
+125% +$29.6M
BMY icon
221
Bristol-Myers Squibb
BMY
$134B
$48.1M 0.09%
813,439
-559,300
-41% -$36.8M
HRMY icon
222
Harmony Biosciences
HRMY
$2.06B
$47.5M 0.09%
+1,240,415
New +$39.9M
EOG icon
223
EOG Resources
EOG
$77.6B
$47.3M 0.09%
589,800
+306,000
+108% +$22.3M
NEM icon
224
Newmont
NEM
$100B
$46.7M 0.09%
860,600
-10,700
-1% -$631K
MNRL
225
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$46.7M 0.09%
2,435,901
-135,000
-5% -$2.59M

Similar funds

Adage Capital Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Adage Capital Partners held 1,137 positions worth $50.8B, down 0.58% from $51.1B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Adage Capital Partners's Q3 2021 filing shows 127 new, 273 increased, 442 reduced and 122 closed positions. Its largest new stake was Pfizer: 5,759,101 shares worth $248M. The largest sale was Alexion Pharmaceuticals, an estimated $962M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q3 2021 buy was Pfizer: 5,759,101 shares worth $248M.
  • Adage Capital Partners added most to Textron in Q3 2021, an estimated $206M increase.
  • Adage Capital Partners's biggest Q3 2021 reduction was Devon Energy, cutting an estimated $201M.
  • Adage Capital Partners fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $962M.
  • Adage Capital Partners's ten largest holdings make up 22% of its $50.8B portfolio in Q3 2021.
  • Adage Capital Partners opened 127 new positions and closed 122 in Q3 2021.
  • Adage Capital Partners's portfolio value fell 0.58% quarter-over-quarter to $50.8B.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.